Incite Health
Doylestown, Pennsylvania, United States
Our proprietary CNSDose test connects your unique genetics with the latest clinical neuroscience to give you more accurate recommendations, alleviating trial and error of dosage for medications related to depression and anxiety. With a simple at-home cheek swab to collect your DNA, the CNSDose test analyses 15 of your genes. Some of these genes can affect the liver's ability to metabolise medications and others help carry medication to the brain via the blood-brain barrier. Genetic differences in a person can mean they metabolise medications slower or faster, or the medication has difficulty reaching the brain. CNSDose anticipates such responses in you, giving evidence-based dosage recommendations to your Physician tailored to your genetic make-up.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2020
- Website
- www.incitehealth.com/
Categories
Only accessible to MedStartr community members.
Join nowWhat do you think of Incite Health?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now